Who owns BIO
385 institutions reported holding BIO for 2026Q1, together 74% of the company, fewer than the 393 a quarter earlier.
385
Institutions reporting a position · as of 2026Q1 · down from 393 the quarter before
- Shares held by institutions
- 20.0M
Shares held by institutions · 74% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $5.57B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 30%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 57
- Positions exited
- 69
- Added to
- 133
- Reduced
- 88
- Top 10 holdersof the company
- 39%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 385 | 20.0M | $5.57B |
| 2025Q4 | 393 | 19.5M | $5.89B |
| 2025Q3 | 392 | 19.4M | $5.43B |
| 2025Q2 | 377 | 19.1M | $4.61B |
| 2025Q1 | 430 | 19.5M | $4.71B |
| 2024Q4 | 451 | 18.8M | $6.17B |
| 2024Q3 | 432 | 19.4M | $6.48B |
| 2024Q2 | 436 | 19.8M | $5.41B |
| 2024Q1 | 457 | 18.5M | $6.40B |
| 2023Q4 | 476 | 18.5M | $5.98B |
| 2023Q3 | 460 | 18.8M | $6.73B |
| 2023Q2 | 463 | 18.8M | $7.19B |
| 2023Q1 | 498 | 19.2M | $9.19B |
| 2022Q4 | 464 | 19.2M | $8.11B |
| 2022Q3 | 478 | 19.5M | $8.13B |
| 2022Q2 | 494 | 19.1M | $9.45B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| First Eagle Investment Management, LLC | 2.6M | 9.7% | $726M |
| VANGUARD GROUP INC | 1.8M | 6.7% | $504M |
| BlackRock Inc. | 1.7M | 6.2% | $468M |
| DIMENSIONAL FUND ADVISORS LP | 1.1M | 4.0% | $304M |
| ARIEL INVESTMENTS, LLC | 0.8M | 2.9% | $219M |
| EARNEST PARTNERS LLC | 0.6M | 2.2% | $164M |
| STATE STREET CORP | 0.6M | 2.1% | $156M |
| Capital World Investors | 0.5M | 1.7% | $125M |
| BANK OF AMERICA CORP /DE/ | 0.4M | 1.7% | $124M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.4M | 1.6% | $119M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Medical Devices
Ranks #27 of 35 by Smart Score